Linda Llewelyn, the Chief People Officer at Health Catalyst , Inc. (NASDAQ:HCAT), recently sold shares of the company, according to a filing with the Securities and Exchange... In a turbulent ...
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (NASDAQ:HCAT) and its peers. Organizations ...
During the last three months, 8 analysts shared their evaluations of Health Catalyst HCAT, revealing diverse outlooks from bullish to bearish. The following table encapsulates their recent ratings ...
Health Catalyst (NASDAQ:HCAT – Free Report) had its target price decreased by Royal Bank of Canada from $9.00 to $7.00 in a research note released on Wednesday morning,Benzinga reports.
PRVA Privia Health Group, Inc.
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
Canaccord Genuity analyst Richard Close maintained a Buy rating on Health Catalyst (NASDAQ:HCAT) on Thursday, setting a price target of $60, which is approximately 28 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results